Eiger Biopharmaceuticals, Inc.

EIGRQ • OTC

Eiger Biopharmaceuticals, Inc. is a biotechnology company in the healthcare sector on OTC.

Biotechnology

Healthcare

Overview

Overview of institutional ownership in EIGRQ as of Q3 2025

All Institutions

Institutions: 0
Value Held: -
Shares Held: -
Avg Position: -
Median Position: -

Hedge Funds

Hedge Funds: 0
Value Held: -
Shares Held: -
Avg Position: -
Median Position: -

Biggest Investors

Institutions with the largest positions in EIGRQ as of Q3 2025

Institution	Key People	Position Value	Ownership	Owned Since	Total AUM (Long)
Propel Bio Management, LLC Hedge Fund•Sector	Leen Kawas Managing Partner	- 0.00% of portfolio	0.00% - shares	Q1 2024 Held for 1y 8m	$99.9M

Net Capital Flow

Institutional buying and selling activity for EIGRQ in Q3 2025

Traded: −-
Buyers: 0
Sellers: 0
Total Bought: +-
Total Sold: −-
Avg Position: -

Biggest Buyers

Institution	Net Bought	Current Position
No buyers found

Biggest Sellers

Institution	Net Sold	Current Position
No sellers found

Entry and Exit Activity

Institutions that initiated new positions or completely exited EIGRQ in Q3 2025

New Positions: 1
New Value: -
Exited Positions: 1
Exited Value: -

New Positions

Institution	Position Value
Propel Bio Management, LLC Hedge Fund•Sector	- - shares

Exited Positions

Institution	Previous Position
Propel Bio Management, LLC Hedge Fund•Sector	- 146.4K shares

Options Activity

Institutions with the largest Call and Put options positions in EIGRQ as of Q3 2025

Call Positions: 0
Call Value: -
Put Positions: 0
Put Value: -

Call Positions

Institution	Position Value
No call positions found

Put Positions

Institution	Position Value
No put positions found

Most Committed Institutions

Institutions with EIGRQ as the highest % of their portfolio as of Q3 2025

Institution	Key People	Portfolio Weight	Ownership	Owned Since	Total AUM (Long)
Propel Bio Management, LLC Hedge Fund•Sector	Leen Kawas Managing Partner	0.00% -	0.00% - shares	Q1 2024 Held for 1y 8m	$99.9M